Coronary artery disease in the transplanted heart

Area of Science:

• Cardiology
• Immunology
• Transplantation Medicine

Background:

• Coronary artery disease (CAD) is a major limitation to long-term cardiac allograft survival.
• Intravascular ultrasound reveals both donor-transmitted and de novo plaques in transplanted hearts.
• Coronary vasomotor dysfunction can occur independently of plaque morphology.

Purpose of the Study:

• To elucidate the mechanisms of cardiac allograft vasculopathy (CAV).
• To identify potential therapeutic targets for preventing or treating CAV.
• To evaluate current and novel treatment strategies for CAV.

Main Methods:

• Review of intravascular ultrasound studies.
• Analysis of the inflammatory cascade involving T lymphocytes, cytokines, and endothelium.
• Assessment of the role of adhesion molecules, leukocytes, and thrombocytes.
• Evaluation of therapeutic interventions targeting immune activation and endothelial injury.

Main Results:

• CAV involves a complex interplay of immune activation, endothelial dysfunction, and inflammatory responses.
• Upregulated adhesion molecules, leukocyte infiltration, and thrombocyte accumulation contribute to allograft lesions.
• Blocking T cell activation, CD4+ cytokines, and adhesion molecules shows promise in preventing endothelial injury and intimal thickening.

Conclusions:

• Targeting T cell activation, cytokine signaling, and adhesion molecules may prevent endothelial injury and intimal thickening.
• Strategies to reduce anti-endothelial and anti-HLA-DR antibodies, alongside antiproliferative drugs and enhanced nitric oxide, could be protective.
• Revascularization has limited efficacy for focal lesions; retransplantation is controversial but the only definitive treatment.